Acadian Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-964,881
| Closed | -$2.57M | – | 1946 |
|
|
2024
Q1 | $2.57M | Buy |
964,881
+134,388
| +16% | +$357K | 0.01% | 604 |
|
|
2023
Q4 | $1.97M | Buy |
830,493
+93,807
| +13% | +$222K | 0.01% | 676 |
|
|
2023
Q3 | $1.03M | Buy |
736,686
+305,884
| +71% | +$428K | ﹤0.01% | 847 |
|
|
2023
Q2 | $1.3M | Buy |
430,802
+401,887
| +1,390% | +$1.22M | 0.01% | 817 |
|
|
2023
Q1 | $179K | Buy |
28,915
+17,929
| +163% | +$111K | ﹤0.01% | 1278 |
|
|
2022
Q4 | $67K | Buy |
10,986
+2,830
| +35% | +$17.3K | ﹤0.01% | 1516 |
|
|
2022
Q3 | $97K | Sell |
8,156
-2,610
| -24% | -$31K | ﹤0.01% | 1374 |
|
|
2022
Q2 | $136K | Buy |
+10,766
| New | +$136K | ﹤0.01% | 1290 |
|